Benefitfocus, Inc. (NASDAQ:BNFT) reached 108% versus a 1-year low price of $21.75. The stock was last seen -3.46% lower, reaching at $45.24 on 3/14/2019. At a recent session, the prices were hovering between $45 and $47.22. This company shares are 25.11% off its target price of $56.6 and the current market capitalization stands at $1.43B. The recent change has given its price a -12.94% deficit over SMA 50 and -25.42% deficit over its 52-week high. The stock witnessed -17.73% declines, -14.59% declines and 3.88% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found BNFT’s volatility during a week at 3.29% and during a month it has been found around 4.21%.

Benefitfocus, Inc. (BNFT) Top Holders

Institutional investors currently hold around $1.29 billion or 88.9% in BNFT stock. Look at its top three institutional owners: Fmr Llc owns $224.63 million in Benefitfocus, Inc., which represents roughly 15.71% of the company’s market cap and approximately 17.41% of the institutional ownership. Similar statistics are true for the second largest owner, Bamco Inc /Ny/, which owns 4,136,606 shares of the stock are valued at $193.84 million. The third largest holder is Goldman Sachs Group Inc, which currently holds $176.88 million worth of this stock and that ownership represents nearly 12.37% of its market capitalization.

Benefitfocus, Inc. 13F Filings

At the end of December reporting period, 74 institutional holders increased their position in Benefitfocus, Inc. (NASDAQ:BNFT) by some 1,994,872 shares, 53 decreased positions by 4,494,693 and 8 held positions by 21,046,071. That puts total institutional holdings at 27,535,636 shares, according to SEC filings. The stock grabbed 30 new institutional investments totaling 454,858 shares while 11 institutional investors sold out their entire positions totaling 427,341 shares.

Benefitfocus, Inc. (BNFT) Analyst Guide

Several analysts have released their opinion on Benefitfocus, Inc. (NASDAQ:BNFT), with 3 analysts believing it is a strong buy. Whereas 6 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.27 average brokerage recommendation [T1].